Drug · DIN 02526387
MINT-RANITIDINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 7, 2022; first marketed October 7, 2022.
- Drug Identification Number (DIN)
- 02526387
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ranitidine A02BA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANITIDINE (RANITIDINE HYDROCHLORIDE) | 300 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 4, 2022: NOC 27907Abbreviated New Drug Submission (ANDS)
Other DINs named MINT-RANITIDINE
- DIN 02526379 · Marketed